Breast Cancer Clinical Trials in San Antonio, TX

Breast Cancer Clinical Trials in San Antonio, TX

View the best 10 breast cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Breast Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for breast cancer in San Antonio, Texas

Image of Baptist MD Anderson Cancer Center in Jacksonville, United States.

Partial Breast Irradiation

Radiation

Recruiting1 awardPhase 2 & 3
This trial looks at how well a shorter, higher-dose radiation therapy works to treat early stage breast cancer. The cancer is only in the breast, and this treatment may have fewer side effects.
Image of St. Bernards Medical Center in Jonesboro, United States.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Recruiting2 awardsPhase 3
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Image of University of California, Los Angeles in Los Angeles, United States.

DS-1062a

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests a new drug, DS-1062a, on patients with advanced cancers who haven't been cured by other treatments. The goal is to find the safest dose and see if the drug can help treat these cancers.
Image of New York Cancers & Blood Specialists in Port Jefferson Station, United States.

SV-BR-1-GM +1 More

Virus Therapy

Recruiting2 awardsPhase 3
This trial evaluates a new treatment for advanced breast cancer with no other alternatives available.
Image of Pacific Cancer Care ( Site 0142) in Monterey, United States.

Pembrolizumab +1 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two different treatments for triple negative breast cancer - olaparib plus pembrolizumab versus chemotherapy plus pembrolizumab. The primary hypotheses are that olaparib plus pembrolizumab will be superior to chemotherapy plus pembrolizumab in terms of progression-free survival and overall survival.
Image of Highlands Oncology Group Main in Fayetteville, United States.

Trastuzumab

Recruiting1 awardPhase 3
This trial tested a combination of drugs for patients with advanced breast cancer that has a specific genetic mutation. The goal was to see if this combination could better control the cancer by blocking growth signals. The study was stopped due to changes in treatment approaches, not because of safety issues.
Image of Baptist Health Lexington in Lexington, United States.

TOL2506

Chemotherapy

Recruiting2 awardsPhase 3
This trial studies a drug (TOL2506) to suppress ovarian function in premenopausal women and men with breast cancer. A safety extension study will assess its long-term effects.
Image of Kaiser Permanente - Oakland in Oakland, United States.

Letrozole +2 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial will compare two treatments for breast cancer: giredestrant with palbociclib, and letrozole with palbociclib. The trial will measure how well the treatments work and how safe they are.
Image of Research Site in Scottsdale, United States.

Trastuzumab Deruxtecan

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is testing a new drug called trastuzumab deruxtecan for patients with advanced breast cancer that hasn't responded to other treatments. The drug works by specifically targeting and killing cancer cells. The study aims to see if this drug helps patients live longer or improves their quality of life compared to other treatments. Trastuzumab deruxtecan has shown significant clinical benefits in treating advanced breast cancer and other similar tumors.
Image of The University of Texas at Austin in Austin, United States.

CAI +1 More

Behavioural Intervention

Recruiting1 award3 criteria
This trial aims to develop a web-based program called CAI to help Asian American breast cancer survivors manage cancer pain. The program will be tailored to individuals and will also address depressive symptoms. The study will

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.